B58.82 Toxoplasma myositis

Name of the Condition

• Toxoplasma myositis

Summary

Toxoplasma myositis is an inflammatory condition of skeletal muscle caused by infection with the protozoan parasite Toxoplasma gondii. It may present as an acute or chronic process, with clinical severity influenced by the host's immune status and the extent of muscle involvement. While often asymptomatic in immunocompetent individuals, it can lead to significant muscle dysfunction in immunocompromised patients or those with congenital infection.

Causes

The condition is caused by Toxoplasma gondii, a parasite that can infect muscle tissue through congenital transmission or reactivation of latent infection. Transmission occurs via ingestion of contaminated food or water, contact with cat feces containing oocysts, or consumption of undercooked meat harboring tissue cysts. In muscle tissue, the parasite can invade myocytes, triggering inflammatory responses that may impair muscle function.

Risk Factors

• Immunocompromised states, such as HIV/AIDS, organ transplantation, or chemotherapy.
• Pregnancy, especially if the mother acquires the infection during gestation.
• Consumption of undercooked or raw meat, particularly pork, lamb, or venison.
• Exposure to cat feces, including cleaning litter boxes or gardening in soil potentially contaminated with oocysts.
• Advanced age or systemic co-morbidities that weaken immune function.

Symptoms

• Muscle pain (myalgia) or tenderness.
• Muscle weakness or fatigue.
• Swelling or inflammation of affected muscles.
• Fever or systemic symptoms in severe cases.
• Limited range of motion or difficulty with physical activity.

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory testing, and imaging. Serologic tests (e.g., IgG/IgM antibodies) may detect prior or active infection. Muscle biopsy with histopathological examination can identify Toxoplasma gondii organisms or inflammatory changes. Imaging studies, such as MRI or ultrasound, may reveal muscle inflammation or edema. Additional tests, including PCR or antigen detection, may support the diagnosis in specific cases.

Treatment Options

Treatment typically involves antiparasitic medications, such as pyrimethamine combined with sulfadiazine or clindamycin, to target the parasite. Corticosteroids may be used to reduce inflammation in severe cases. Immunocompromised patients often require longer treatment durations. Supportive care, including rest and pain management, may aid recovery. Consultation with an infectious disease specialist is recommended for complex cases.

Prognosis and Follow-Up

Prognosis depends on the host's immune status and timeliness of treatment. Immunocompetent individuals generally have a favorable outcome with appropriate therapy. Immunocompromised patients or those with severe muscle involvement may experience prolonged recovery or residual symptoms. Follow-up includes monitoring for treatment response, assessing muscle function, and evaluating for recurrence or complications. Regular clinical reviews are advised, especially in high-risk populations.

Complications

• Persistent muscle weakness or atrophy.
• Chronic pain or functional impairment.
• Secondary infections due to muscle damage.
• Systemic spread of infection in immunocompromised patients.
• Rarely, severe complications like rhabdomyolysis or organ failure.

Lifestyle & Prevention

• Practice safe food handling: cook meat thoroughly and avoid cross-contamination.
• Wash fruits and vegetables thoroughly before consumption.
• Avoid contact with cat feces; delegate litter box cleaning to others if possible.
• Wear gloves when gardening or handling soil.
• Maintain good hygiene, including handwashing after handling raw meat or soil.

When to Seek Professional Help

Seek medical attention if you experience unexplained muscle pain, weakness, or fever, especially if you are immunocompromised, pregnant, or have been exposed to potential sources of infection. Prompt evaluation is important for early diagnosis and treatment to prevent complications.

Tips for Medical Coders

Document the clinical findings supporting muscle inflammation and infection with Toxoplasma gondii, including biopsy results, serologic tests, or imaging. Ensure the diagnosis aligns with the specific muscle involvement (e.g., myositis) and exclude other causes of muscle inflammation. Code B58.82 is appropriate when the infection is localized to muscle tissue and not part of a broader systemic or organ-specific toxoplasmosis presentation. Verify documentation for acute versus chronic presentation and any associated risk factors (e.g., immunocompromised status) to support coding accuracy.